Article
BTK: 22 novel and 25 recurrent mutations in European patients with X-linked agammaglobulinemia.
Human mutation - 1 Mar 2004
Fiorini Maurilia, Franceschini Roberta, Soresina Annarosa, Schumacher Richard-Fabian, Ugazio Alberto G, Rossi Paolo, Plebani Alessandro, Notarangelo Luigi D
Abstract excerpt
X linked agammaglobulinemia (XLA) is an immunodeficiency disease caused by mutations in the gene coding for Bruton's agammaglobulinemia tyrosine kinase (BTK), that is involved in signal transduction pathways regulating survival, activation, proliferation, and differentiation of B lineage lymphoid cells. XLA is a primary immunodeficiency disorder characterized by lack of mature, circulating B lymphocytes, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
